MIRA
INFORM REPORT
|
Report Date : |
20.12.2011 |
IDENTIFICATION DETAILS
|
Name : |
ZYDUS NYCOMED HEALTHCARE PRIVATE LIMITED (w.e.f. 07.07.2007) |
|
|
|
|
Formerly Known As : |
ZYDUS ALTANA HEALTHCARE PRIVATE LIMITED |
|
|
|
|
Registered Office : |
C-4, MIDC Estate, Village Pawne, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
30.03.1999 |
|
|
|
|
Com. Reg. No.: |
11-119171 |
|
|
|
|
Capital Investment / Paid-up Capital : |
Rs.200.000 millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24231MH1999PTC119171 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMZ01073C |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACZ0736D |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
A (65) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 7500000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established and reputed company having fine track. Financial positions of the company appears to be sound. Trade
relations are reported as fair. Business is active. Payments are reported to
be regular and as per commitments. The company can be considered good for normal business dealings at
usual trade terms and conditions. The Profit and Loss for the year 2010 is not available. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
C-4, MIDC Estate, Village Pawne, |
|
Tel. No.: |
91-22-27682666 / 65163859 |
|
Fax No.: |
91-22-27670223 / 27670224 |
|
E-Mail : |
srinavas.shankar@zydusnycomed.com
|
|
Website : |
DIRECTORS
As on 23.06.2011
|
Name : |
Mr. Krishnan Ravichandran |
|
Designation : |
Managing Director |
|
Address : |
16201, Bansari Bhuvan, Sion East, Mumbai- 400022, |
|
Date of Birth/Age : |
17.03.1957 |
|
Date of Appointment : |
01.11.2002 |
|
DIN No.: |
00295481 |
|
|
|
|
Name : |
Mr. Pankajbhai Ramanbhai Patel |
|
Designation : |
Director |
|
Address : |
16, Azad Society, Ambawadi, Ahmedabad- 380015, |
|
Date of Birth/Age : |
16.03.1953 |
|
Date of Appointment : |
30.03.1999 |
|
DIN No.: |
00131852 |
Other Directorship
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company Status |
Defaulting
status |
|
1 |
U24231GJ1973PLC002286 |
Cadila
Laboratories Private Limited |
Director |
09-03-78 |
09-03-78 |
- |
Active |
NO |
|
2 |
U65910GJ1980PTC004056 |
Pripan Investment
Private Limited |
Director |
01-12-80 |
01-12-80 |
- |
Active |
NO |
|
3 |
U68186GJ1973PTC002373 |
Cadmach
Machinery Company Private Limited |
Director |
01-12-08 |
16-02-90 |
- |
Active |
NO |
|
4 |
U24239MH1991PLC059995 |
Pharmaceutical Business
Group( |
Director |
25-01-91 |
25-01-91 |
16-05-08 |
Active |
NO |
|
5 |
L24230GJ1981PLC004878 |
Gujarat Themis
Biosyn Limited |
Director |
15-01-92 |
15-01-92 |
25-10-08 |
Active |
NO |
|
6 |
U24231GJ1994PLC023298 |
Zydus Pharmaceuticals
Limited |
Director |
17-10-94 |
17-10-94 |
- |
Active |
NO |
|
7 |
U65910GJ1994PLC023467 |
Zydus
Infrastructure Private Limited |
Director |
31-10-94 |
31-10-94 |
- |
Active |
NO |
|
8 |
L24230GJ1995PLC025878 |
Cadila
Healthcare Limited |
Managing
director |
15-05-95 |
15-05-95 |
- |
Active |
NO |
|
9 |
L24231GJ1991PLC015390 |
Vadilal
Chemicals Limited |
Director |
01-12-95 |
01-12-95 |
- |
Active |
NO |
|
10 |
U24231MH1999PTC119171 |
Zydus Nycomed
Healthcare Private Limited |
Nominee director |
30-03-99 |
30-03-99 |
- |
Active |
NO |
|
11 |
U85110GJ2000PLC037488 |
Dialforhealth
India Limited |
Nominee director |
06-03-00 |
06-03-00 |
- |
Active |
NO |
|
12 |
U24239DL2000PLC104724 |
Zydus Animal
Health Limited |
Nominee director |
27-03-00 |
27-03-00 |
- |
Active |
NO |
|
13 |
U73100GJ2004PLC044669 |
Cliantha
Research Limited |
Director |
30-08-04 |
30-08-04 |
26-09-08 |
Active |
NO |
|
14 |
U73100GJ2005PTC046914 |
Zydus Bsv
Research And Development Private Limited |
Director |
25-08-06 |
07-04-06 |
- |
Amalgamated |
NO |
|
15 |
U24230GJ2005PTC046915 |
Zydus Bsv Pharma
Private Limited |
Director |
25-08-06 |
07-04-06 |
15-03-08 |
Active |
NO |
|
16 |
U73100GJ2006PLC048915 |
Baap Diagnostics
Limited |
Nominee director |
21-08-06 |
21-08-06 |
- |
Active |
NO |
|
17 |
L31200GJ2004PLC044068 |
Torrent Power
Limited |
Director |
15-12-06 |
29-09-06 |
- |
Active |
NO |
|
18 |
L24240GJ1980PLC003670 |
Nirma Limited |
Director |
25-09-07 |
28-10-06 |
- |
Active |
NO |
|
19 |
U24233GJ2007PTC050538 |
Mabs Biotech
Private Limited |
Nominee director |
16-04-07 |
16-04-07 |
- |
Active |
NO |
|
20 |
U24239MH1982PLC028137 |
Liva Healthcare
Limited |
Nominee director |
18-04-07 |
18-04-07 |
14-08-07 |
Active |
NO |
|
21 |
U85110GJ2008PTC052902 |
|
Director |
13-02-08 |
13-02-08 |
- |
Amalgamated |
NO |
|
22 |
U24233GJ2008PTC054191 |
|
Director |
12-06-08 |
12-06-08 |
- |
Active |
NO |
|
23 |
U92410GJ1989GAP012192 |
Karnavati Club
Limited |
Director
appointed in casual vacancy |
21-12-08 |
21-12-08 |
- |
Active |
NO |
|
24 |
U70101GJ2009PTC056074 |
Zandra
Infrastructure Private Limited |
Director |
06-02-09 |
06-02-09 |
21-02-09 |
Converted to LLP
and dissolved |
NO |
|
25 |
U24230GJ2009PLC056149 |
Zydus
Technologies Limited |
Director |
16-02-09 |
16-02-09 |
- |
Active |
NO |
|
26 |
U90000GJ2009PTC056367 |
Western
Ahmedabad Effluent Conveyance Company Private Limited |
Director |
16-03-09 |
16-03-09 |
- |
Active |
NO |
|
27 |
L15201GJ1994PLC023490 |
Zydus Wellness
Limited |
Director |
28-07-09 |
27-04-09 |
- |
Active |
NO |
|
28 |
U85110GJ2011PTC064016 |
Zydus Hospitals
(Vadodra) Private Limited |
Director |
11-02-11 |
11-02-11 |
- |
Active |
NO |
|
29 |
U85110GJ2011PTC064017 |
Zydus Hospitals
( |
Director |
11-02-11 |
11-02-11 |
- |
Active |
NO |
|
30 |
U24233MH2011PTC213118 |
Bayer Zydus
Pharma Private Limited |
Additional
director |
28-04-11 |
28-04-11 |
- |
Active |
NO |
|
|
|
|
Name : |
Mr. Ganesh Narayan Nayak |
|
Designation : |
Director |
|
Address : |
3, Ashwamegh Part-5, |
|
Date of Birth/Age : |
18.05.1955 |
|
Date of Appointment : |
28.04.1999 |
|
DIN No.: |
00017481 |
Other Directorship
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date of
appointment |
Company Status |
Defaulting
status |
|
1 |
U24231MH1999PTC119171 |
Zydus Nycomed
Healthcare Private Limited |
Nominee director |
28-04-99 |
28-04-99 |
Active |
NO |
|
2 |
U24239DL2000PLC104724 |
Zydus Animal
Health Limited |
Nominee director |
03-04-00 |
03-04-00 |
Active |
NO |
|
3 |
U24230GJ2005PTC046246 |
Zydus Hospira
Oncology Private Limited |
Director |
24-01-06 |
24-01-06 |
Active |
NO |
|
4 |
U24230GJ2005PTC046915 |
Zydus BSV Pharma
Private Limited |
Director |
25-08-06 |
07-04-06 |
Active |
NO |
|
5 |
U73100GJ2005PTC046914 |
Zydus BSV
Research and Development Private Limited |
Director |
25-08-06 |
07-04-06 |
Amalgamated |
NO |
|
6 |
L15201GJ1994PLC023490 |
Zydus Wellness
Limited |
Director |
29-09-06 |
27-07-06 |
Active |
NO |
|
7 |
U24239MH1982PLC028137 |
Liva Healthcare
Limited |
Nominee director |
18-04-07 |
18-04-07 |
Active |
NO |
|
8 |
U85100MH2010PTC208778 |
Violio Pharma
Private Limited |
Director |
07-10-10 |
07-10-10 |
Active |
NO |
|
9 |
U24233MH2011PTC213118 |
Bayer Zydus Pharma
Private Limited |
Additional
director |
24-03-11 |
24-03-11 |
Active |
NO |
|
10 |
U74140DL2010PLC210936 |
Finest Procuring
Solutions Limited |
Additional
director |
27-07-11 |
27-07-11 |
Active |
NO |
|
|
|
|
Name : |
Mr. Barthold Piening |
|
Designation : |
Director |
|
Address : |
Feursteinstr 55, 78479, |
|
Date of Appointment : |
08.12.2006 |
|
DIN No.: |
00418019 |
|
|
|
|
Name : |
Mr. Sven Anders Ernst Uddo Ullman |
|
Designation : |
Director appointed in casual vacancy |
|
Date of Appointment : |
09.03.2010 |
|
DIN No.: |
02349238 |
Other Directorship
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date of
appointment |
Company Status |
Defaulting
status |
|
1 |
U24239MH2003PTC148545 |
Nycomed Pharma
Private Limited |
Director |
04-09-08 |
04-09-08 |
Active |
NO |
|
2 |
U24231MH1999PTC119171 |
Zydus Nycomed
Healthcare Private Limited |
Director appointed
in casual vacancy |
09-03-10 |
09-03-10 |
Active |
NO |
|
|
|
|
Name : |
Mr. Guido Oelkers |
|
Designation : |
Director appointed in casual vacancy |
|
Date of Appointment : |
09.03.2010 |
|
DIN No.: |
00971915 |
Other Directorship
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company Status |
Defaulting
status |
|
1 |
U74130GJ2001PTC039600 |
Invida India Private
Limited |
Director |
07-09-06 |
07-09-06 |
29-08-08 |
Active |
NO |
|
2 |
U24231MH1999PTC119171 |
Zydus Nycomed
Healthcare Private Limited |
Director
appointed in casual vacancy |
09-03-10 |
09-03-10 |
- |
Active |
NO |
|
3 |
U24239MH2003PTC148545 |
Nycomed Pharma
Private Limited |
Additional
director |
05-10-10 |
05-10-10 |
21-09-11 |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. Srinivas Sankaranarayanan |
|
Designation : |
Company Secretary |
|
Address : |
Parag Plot 48, Ground Floor, Brahmanwada, Matunga- Central, Mumbai-
400019, Maharashtra, India |
|
Date of Birth/Age : |
15.05.1968 |
|
Date of Appointment : |
16.06.2007 |
|
PAN No.: |
ABFPS0670J |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 23.06.2011
|
Names of Shareholders |
|
No. of Shares |
|
Pankajbhai Ramanbhai Patel |
|
100 |
|
Cadila Healthcare Limited, |
|
9999900 |
|
Nycomed Asset Management |
|
9700000 |
|
Nycomed |
|
300000 |
|
Total |
|
20000000 |
As on 23.06.2011
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others] |
|
50.00 |
|
Bodies
corporate |
|
50.00 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of |
||||||
|
|
|
||||||
|
Products : |
|
PRODUCTION STATUS AS ON 31.12.2010
|
Particulars |
Unit |
Licensed
Capacity |
Installed
Capacity * |
Actual
Production |
|
KSM-6 (2 Chloromethyl 3-4 Dimethoxy Puridum Chloride) |
Metric Tonnes |
75.00 |
60.00 |
63.88 |
|
KSM-14 (5 Ditluromethoxy-2-Mercapto-1H-Benzimidazole) |
Metric Tonnes |
75.00 |
60.00 |
65.63 |
* As certified by the Management.
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|
|
|
|
Bankers : |
Not Available |
|
Banking
Relations : |
--- |
|
|
|
|
Auditors : |
|
|
Name : |
S. R. Batliboi and Company Chartered Accountants |
|
Address : |
Jalan Mill Compound, 95, Ganpatrao Kadam Marg, Lower Parel, Mumbai –
400 013, |
|
Tel. No.: |
91-22-40356300 |
|
Fax No.: |
91-22-40356400 |
|
PAN No.: |
AALFS0506L |
|
|
|
|
Enterprises where control exists : |
·
Nycomed Asset Management GmbH (‘ ·
Cadila Healthcare Limited (CHL) (holds 50% of the
equity share capital as at December 31, 2010 along with Nominee) |
|
|
|
|
Fellow Subsidiaries : |
·
Nycomed GmbH ·
Nycomed Pharma Private Limited |
CAPITAL STRUCTURE
As on 23.06.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
20000000 |
Equity Shares |
Rs.10/- each |
Rs.200.000 Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
20000000 |
Equity Shares |
Rs.10/- each |
Rs.200.000 Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.12.2010 |
31.12.2009 |
31.12.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
200.000 |
200.000 |
200.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
1673.961 |
1523.370 |
1097.662 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
1873.961 |
1723.370 |
1297.662 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
0.000 |
0.000 |
0.000 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
1873.961 |
1723.370 |
1297.662 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
385.783 |
209.547 |
231.393 |
|
|
Capital work-in-progress |
610.281 |
371.418 |
19.123 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
472.583
|
317.445 |
255.030 |
|
|
Sundry Debtors |
0.000
|
0.000 |
0.000 |
|
|
Cash & Bank Balances |
204.471
|
984.074 |
428.918 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
430.791
|
69.425 |
427.541 |
|
Total
Current Assets |
1107.845
|
1370.944 |
1111.489 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
192.669 |
52.329 |
|
|
Other Current Liabilities |
|
2.664 |
1.886 |
|
|
Provisions |
24.342
|
33.206 |
10.128 |
|
Total
Current Liabilities |
229.948
|
228.539 |
64.343 |
|
|
Net Current Assets |
877.897
|
1142.405 |
1047.146 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
1873.961 |
1723.370 |
1297.662 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.12.2010 |
31.12.2009 |
31.12.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
NA |
1846.134 |
1814.360 |
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL |
NA |
1846.134 |
1814.360 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Office Expenses |
NA |
483.853 |
367.886 |
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL |
NA |
483.853 |
367.886 |
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS)
BEFORE TAX, DEPRECIATION AND AMORTISATION |
NA |
1362.281 |
1446.474 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
NA |
30.992 |
41.530 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS)
BEFORE TAX |
NA |
1331.289 |
1404.944 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
NA |
191.910 |
163.601 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS)
AFTER TAX |
NA |
1139.379 |
1241.343 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
NA |
332.844 |
34.600 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
NA |
113.937 |
124.134 |
|
|
|
Interim Dividend – I |
NA |
100.000 |
200.000 |
|
|
|
Interim Dividend – II |
NA |
200.000 |
200.000 |
|
|
|
Interim Dividend – III |
NA |
110.000 |
300.000 |
|
|
|
Interim Dividend – IV |
NA |
200.000 |
0.000 |
|
|
|
Dividend Distribution Tax |
NA |
103.669 |
118.965 |
|
|
BALANCE CARRIED
TO THE B/S |
NA |
644.617 |
332.844 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
FOB value of exports |
1286.225 |
1777.759 |
1740.118 |
|
|
|
Reimbursement of expenses incurred on Trail Run Inventory |
16.095 |
0.000 |
0.000 |
|
|
TOTAL EARNINGS |
1302.320 |
1777.759 |
1740.118 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials and Packing Materials |
59.876 |
83.360 |
NA |
|
|
|
Raw Materials (Validation Batches) |
10.096 |
48.262 |
NA |
|
|
|
Store parts and Components |
0.000 |
3.406 |
NA |
|
|
|
Capital Goods |
87.026 |
9.691 |
NA |
|
|
TOTAL IMPORTS |
156.998 |
144.719 |
NA |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
NA |
56.97 |
62.07 |
|
KEY RATIOS
|
PARTICULARS |
|
31.12.2010 |
31.12.2009 |
31.12.2008 |
|
PAT / Total Income |
(%) |
NA
|
61.72 |
68.42 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
NA
|
84.23 |
104.62 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
NA
|
0.77 |
1.08 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.12
|
0.13 |
0.05 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
4.82
|
6.00 |
17.27 |
LOCAL AGENCY FURTHER INFORMATION
NATURE OF
OPERATIONS
The Company a private limited company registered under the Companies
Act, 1956 is 100% export oriented unit engaged in manufacturing active
pharmaceuticals ingredients for Group Companies.
CONTINGENT
LIABILITIES
|
Particulars |
As
on 31.12.2010 Rs.
in millions |
|
Income Tax matters in respect of which : |
|
|
Tax authorities have appealed against Income tax orders which were
ruled in favour of the Company |
1127.039 |
|
Company’s appeals are pending before appropriate authorities |
1137.842 |
Contingent liabilities in respect of pending tax assessments in relation
to similar matters are not determinable and hence not disclosed.
FIXED ASSETS
·
·
Building - Factory
·
Building - Non Factory
·
Plant and Machinery
·
Electrical Equipments
·
Computers
·
Motor Vehicles
·
Office Equipments
·
Furniture and Fixtures
WEB DETAILS
They were born in 1999 as Zydus BYK Healthcare
Private Limited due to a Joint Venture strategic alliance between BYK Gulden (
In the beginning of the year 2007, NYCOMED, another European Pharma
Company with headquarters in
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.95 |
|
|
1 |
Rs.82.04 |
|
Euro |
1 |
Rs.68.91 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
65 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.